In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 97 for your search:
Country:  U.S.A.
Trial Type:  Prevention
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Natural history/Epidemiology, Prevention
Status: Active
Age: 70 and over
Sponsor: Other
Protocol IDs: 1U01AG029824-01A2, NCT01038583

2.

Phase: Phase IV
Type: Behavioral study, Prevention
Status: Active
Age: 16 to 45
Sponsor: Other
Protocol IDs: P50DA016511, NCT00664755

3.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 11 to 17
Sponsor: Other
Protocol IDs: GardasilMerckGomez-Lobo, NCT01101750

4.

Phase: Phase IV
Type: Behavioral study, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 1U01CA 159533-01, NCT01289275

5.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 55 and over
Sponsor: NCI, Other
Protocol IDs: ROI10-352, R01CA138627, NCT01296672

6.

Phase: Phase IV
Type: Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10-0933, NCT01229319

7.

Phase: Phase III, Phase II
Type: Behavioral study, Prevention
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: NIDA-16427-5, R01-16427-5, DPMC, NCT00132821

8.

Phase: Phase III, Phase II
Type: Behavioral study, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 15597, 5R01AA019720-02, NCT01182766

9.

Phase: Phase III
Type: Prevention
Status: Active
Age: 30 to 75
Sponsor: Other
Protocol IDs: GD-10-08, NCT00808522

10.

Phase: Phase III
Type: Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000681457, U01CA121947, AMC-076, NCT01164722

11.

Phase: Phase III
Type: Prevention
Status: Active
Age: 26 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 113621, NCT01190189

12.

Phase: Phase III
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: S0820, U10CA037429, NCI-2012-02067, NCT01349881

13.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: CPP-FAP-310, NCT01483144

14.

Phase: Phase III
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 50 to 60
Sponsor: Other
Protocol IDs: 2011-0739, NCT01697566

15.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 9 to 14 and 16-26
Sponsor: Pharmaceutical / Industry
Protocol IDs: V503-010, 2013-001314-15, NCT01984697

16.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01434, CDR0000671302, NCI09-13-02, NWU09-13-02, N01CN35157, NU-NWU09-13-02, NCT01111292

17.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 200806, NCT01425476

18.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 200807-001, NCT01769625

19.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 20 to 65
Sponsor: Other
Protocol IDs: R01CA1000853, NCT01790204

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000579360, UAB-F060511015, UAB-IRB0000196, F060511015, NCT00703196

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 21 to 70
Sponsor: NCI, Other
Protocol IDs: 2007NT127, R01CA122244, 0712M22651, UMN-2007NT127, PEITC, NCT00691132

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: CLIN-005-08S, NCT00780234

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 35 to 55
Sponsor: Other
Protocol IDs: V0407, CHRMS#: 05-059, NCT00914017

24.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Status: Active
Age: 40 to 120
Sponsor: NCI
Protocol IDs: NCI-2009-01192, 09-001758, MC054A, R01-CA-113681, P30CA015083, NCT00983580

25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 50
Sponsor: NCI, Other
Protocol IDs: S0812, U10CA037429, NCI-2011-02032, SWOG-S0812, NCT01097278
1     
New Search